Articles, Cellular/Molecular
Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model
Francesco Papaleo, Feng Yang, Clare Paterson, Sara Palumbo, Gregory V. Carr, Yanhong Wang, Kirsten Floyd, Wenwei Huang, Craig J. Thomas, Jingshan Chen, Daniel R. Weinberger and Amanda J. Law
Journal of Neuroscience 27 April 2016, 36 (17) 4859-4875; DOI: https://doi.org/10.1523/JNEUROSCI.4632-15.2016
Francesco Papaleo
1Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892,
2Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, via Morego, 30, Genova 16163, Italy,
Feng Yang
1Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892,
3Lieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, Maryland 21205,
Clare Paterson
4University of Colorado, School of Medicine, Department of Psychiatry, Aurora, Colorado 80045,
Sara Palumbo
1Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892,
5Laboratory of Molecular Biology, Department of Surgical, Medical and Molecular Pathology and of Critical Care, University of Pisa, Pisa I-56126, Italy,
Gregory V. Carr
1Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892,
5Laboratory of Molecular Biology, Department of Surgical, Medical and Molecular Pathology and of Critical Care, University of Pisa, Pisa I-56126, Italy,
Yanhong Wang
1Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892,
3Lieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, Maryland 21205,
Kirsten Floyd
4University of Colorado, School of Medicine, Department of Psychiatry, Aurora, Colorado 80045,
Wenwei Huang
6National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850,
Craig J. Thomas
6National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850,
Jingshan Chen
1Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892,
Daniel R. Weinberger
1Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892,
3Lieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore, Maryland 21205,
7Departments of Psychiatry, Neurology, and Neuroscience, and the McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, and
Amanda J. Law
1Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892,
4University of Colorado, School of Medicine, Department of Psychiatry, Aurora, Colorado 80045,
8University of Colorado, School of Medicine, Department of Cell and Developmental Biology, Aurora, Colorado 80045

Published eLetters
Guidelines
As a forum for professional feedback, submissions of letters are open to all. You do not need to be a subscriber. To avoid redundancy, we urge you to read other people's letters before submitting your own. Name, current appointment, place of work, and email address are required to send a letter, and will be published with your review. We also require that you declare any competing financial interests. Unprofessional submissions will not be considered or responded to.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Neuroscience
Vol. 36, Issue 17
27 Apr 2016
Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model
Francesco Papaleo, Feng Yang, Clare Paterson, Sara Palumbo, Gregory V. Carr, Yanhong Wang, Kirsten Floyd, Wenwei Huang, Craig J. Thomas, Jingshan Chen, Daniel R. Weinberger, Amanda J. Law
Journal of Neuroscience 27 April 2016, 36 (17) 4859-4875; DOI: 10.1523/JNEUROSCI.4632-15.2016
Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model
Francesco Papaleo, Feng Yang, Clare Paterson, Sara Palumbo, Gregory V. Carr, Yanhong Wang, Kirsten Floyd, Wenwei Huang, Craig J. Thomas, Jingshan Chen, Daniel R. Weinberger, Amanda J. Law
Journal of Neuroscience 27 April 2016, 36 (17) 4859-4875; DOI: 10.1523/JNEUROSCI.4632-15.2016
Jump to section
Responses to this article
Jump to comment:
No eLetters have been published for this article.